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Abstract 
Aim: To profile gingival tissue levels of human beta-defensin (hBD)-2 and hBD-3 in relation to 
gingival inflammation, Th17-related cytokine concentrations, Porphyromonas gingivalis counts, 
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Materials and Methods: Gingival tissue and subgingival plaque samples were collected from 21 
periodontitis patients including 48 periodontal pocket sites with marginal, mild, or moderate to 
severe inflammation. hBD levels were determined by immunodetection, P. gingivalis counts with 
real-time polymerase chain reaction, protease activities with fluorogenic substrates, and cytokine 
concentrations with Luminex technique. Data were statistically analyzed using Kruskal-Wallis and 
Mann-Whitney U tests and Spearman correlation coefficients.
Results: Subgingival plaque counts of P. gingivalis (p=0.001) and gingipain activity (p<0.001), as 
well as interleukin (IL)-1β (p=0.012), IL-10 (p=0.024), IL-17A (p=0.002), IL-17F (p=0.006), and 
IL-23 (p=0.036) concentrations were elevated in severely inflamed sites, whereas no change was 
observed in hBD-2 and hBD-3 levels. Negative correlations were found between protease activity 
and hBD-2 (p=0.033) and hBD-3(p=0.003) levels.
Conclusions: Shift in gingival inflammation from marginal to mild stage is related to elevations in 
subgingival plaque P. gingivalis counts and gingipain activity, but not to tissue hBD levels. 
Negative correlations between hBDs and total protease activity suggest the degradation of these 
antimicrobial peptides in progressed inflammation. 
Keywords: Periodontitis, antimicrobial peptides, hBD-2, hBD-3, Porphyromonas gingivalis, 
gingipain, inflammatory cytokines.
Clinical Relevance: 
Scientific rationale for study: Human beta-defensins (hBDs) are small cationic peptides with 
antimicrobial and immune-regulatory roles and their expression and secretion are dependent on 
environmental (bacterial and inflammatory stimulation) and genetic factors. 
Principal findings: Here, we demonstrated that the tissue hBD-2 and hBD-3 levels negatively 
correlate with enzymatic activity while Th17-related cytokine concentrations, Porphyromonas 
gingivalis counts, and gingipain activities relate to clinical gingival inflammation.
Practical implications: Understanding the activation and inactivation mechanisms of these 
antimicrobial and immune-regulatory peptides may enable to benefit from these biomolecules 
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Introduction
Human beta-defensins (hBDs) are small, cysteine-rich cationic peptides with bi-directional 
regulatory relations to the adaptive immune system, angiogenesis, and wound healing (Suarez-
Carmona et al., 2015). Gingival hBDs are produced by epithelial cells (Gomes and Fernandes, 
2010)  and are released into saliva (Gürsoy et al., 2016) and gingival crevicular fluid (Ertugrul et 
al., 2014, Yilmaz et al., 2018). While hBD-1 is secreted constitutively in periodontal tissues, hBD-
2 and hBD-3 secretions are activated by bacterial or inflammatory stimuli (Ganz, 2003). 
Porphyromonas gingivalis is a Gram-negative, anaerobic, asaccharolytic, non-motile bacterium 
(Darveau et al., 2012). P. gingivalis gingipains are cysteine proteinases with a
trypsin-like activity, including lysine-specific gingipain (Kgp) and arginine-specific
gingipains (RgpA and RgpB); they account for 85% of the total proteolytic activity of P.
gingivalis (Potempa et al. 1997). Gingipains selectively subverts the host’s innate and
adaptive immunity by inactivating anti-inflammatory cytokines and degrading antimicrobial
peptides, including hBDs (Carlisle et al., 2009; Maisetta et al. 2011). 
On one hand, cytokines, such as interleukin (IL)-1β, IL-6, and IL-23, influence the differentiation 
of T helper 17 (Th17) cells. As a consequence, the increased release of Th17-related cytokines 
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stimulates or suppresses the secretion of these antimicrobial peptides, depending on the virulence 
of the bacteria involved (Diamond and Ryan, 2011, Gursoy et al., 2012). Here, we hypothesized 
that clinical inflammation and Th17-related inflammatory cytokines activate; whereas P. 
gingivalis, its gingipain activity, and total protease activity suppress hBD levels in periodontally 
inflamed gingival tissue. In the present study, the aim was to profile the levels of hBD-2 and hBD-
3 in tissue samples with a specific reference for the severity and extent of clinical gingival 
inflammation and further, to correlate them with hBD-activating Th17-related cytokine 
concentrations, P. gingivalis counts, and hBD-degrading gingipain and total protease activities.
Materials and Methods
Ethical Guidelines
The study protocol (no: GO 17/786-34) was approved by the Ethical Committee of Hacettepe 
University, Ankara, Turkey in accordance with Helsinki Declaration 1975, as revised in year 
2000. Oral and written information about the study protocol were given to potential participants. 
An informed consent was obtained from those willing to participate in the study.
Study Population
For the sample size calculation, GLIMMPSE 2.0.0 (General Linear Multivariate Model & Sample 
Size), which is a tool for calculating power and sample size in multilevel and longitudinal studies 
with an α=0.05 and β=0.10 targeting for 90% power with three response variables, was used. In 
the calculations, mean values and standard deviations for P. gingivalis α-haemolytic, β-haemolytic 
and non-haemolytic counts were based on a study by Wong et al. (Wong et al., 2016). Since 
changes in variability can dramatically affect power and sample size results, a scale factor was 
used to evaluate the sample size in case of variability in the present study is bigger than that in the 
reference study. It was assumed that the correlation coefficient between periodontal pockets with 
and without infection would be 0.3 and the correlation coefficient between the different responses 
would be 0.7. These analyses indicated that a required sample size would be a minimum of 16 
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Twenty-one periodontitis patients (13 males and 8 females with age range of 24-70 years) referred 
to the Hacettepe University, Faculty of Dentistry, Department of Periodontology, were recruited 
for the study. These periodontitis patients were the first to apply for the study and fit to the 
inclusion criteria [met the criteria of the 2017 World Workshop for classification of periodontal 
and peri-implant diseases (Papapanou et al., 2018)]. Exclusion criteria included systemic diseases, 
smoking, pregnancy, lactation, use of antibiotics and/or anti-inflammatory drugs within 3 months 
preceding the study and periodontal treatment within 6 months before the baseline. 
Periodontal Examination
A full periodontal examination was performed by a single calibrated examiner (M.Ö.). Probing 
pocket depth (PPD), modified gingival index (MGI) (Lobene, 1986), clinical attachment level 
(CAL), plaque index (PI) (Löe, 1967) and bleeding on probing (BOP) (Ainamo and Bay, 1975) 
were recorded at 4 sites (mesio-buccal, mid-buccal, disto-buccal, lingual/palatinal) per tooth  by 
using a manual periodontal probe (UNC-15, Hu-Friedy, Chicago, IL, USA). Orthopantomographs 
were taken (Sirona Orthophos XG5, NY, USA) from all individuals to evaluate the presence and 
extent of alveolar bone loss at the sampling sites. The extent of alveolar bone loss (ABL) was 
graded into three categories: mild: ABL in cervical third of the root; moderate, ABL in the middle 
third of the root; and severe, ABL from the apical third of the root (Salminen et al., 2014).
A total of 48 periodontal pocket sites (2 to 3 sites/patient) with PPD of 5-7 mm were included in 
the study. All pocket sites with PPD 5-7 mm were included unless the patient had more than one 
periodontal pocket with the same degree of inflammation and pocket depth. In such cases, only the 
tooth site that best reflects the degree of inflammation and being easily isolated (e.g. maxilla, 
anterior region) was enrolled for sample collection. 
Based on the degree of inflammation as assessed by the MGI, the sampling sites were divided into 
three study groups: 
Group 1: Marginal inflammation, slight changes in color and texture but not in all portions of 
gingival margin or papilla (n=13),
Group 2: Mild inflammation, slight changes in color and texture in all portions of gingival margin 
or papilla (n=16),
Group 3: Moderate to severe inflammation, bright surface, erythema, edema, ulceration or 
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Levels of clinical parameters (PPD, MGI, CAL, PI, ABL) for each group are given in Table 1.
Clinical Sample Collection
Subgingival plaque was collected by paper points as described elsewhere (Belibasakis et al., 
2014). Briefly, after removing the supragingival plaque, 3 sterile absorbent paper points (size 40, 
VDW, Munich, Germany) were gently inserted apically into the same periodontal pocket, 
removed after 15 s and placed in an Eppendorf tube containing 500 l of phosphate-buffered 
saline (PBS). 
Inflamed gingival granulation tissue was excised from the lateral pocket wall and junctional 
epithelium by using the sharp side of a Gracey curette (Hu-Friedy, Chicago, IL). Excision 
involved the entire pocket starting from the bottom of the periodontal pocket and ended at the 
marginal gingiva, preferably with a single stroke. Granulation tissue samples were placed in an 
Eppendorf tube containing 100 l of PBS. The tissue samples and the paper points were 
immediately placed and stored at -80°C and transferred with dry ice to the Institute of Dentistry, 
University of Turku, Finland, for the laboratory analyses.
Sample Preparations
Each bacterial plaque sample was vortexed for 30 s and the suspension was aliquoted for analyses 
of gingipain and total protease activities and P. gingivalis concentrations. 
Each granulation tissue sample was cut in small pieces, put into 500 l of lysis buffer (50 mM 
Tris-Cl, 150 mM NaCl and 1% Triton X-100), vortexed for 10 s, and incubated at 4°C for 24 h. 
After incubation, tissues were centrifuged at 10 000 g for 1 min and supernatants were obtained. 
Activation of proteases during the extraction process was inhibited by performing the entire 
procedure at 4°C. The supernatants were aliquoted for determinations of gingipain and total 
protease activities, and P. gingivalis, hBD-2, hBD-3, and inflammatory cytokine concentrations.
Determination of P. gingivalis Counts
For the DNA extractions, 250 l of bacterial plaque samples and 100 l of gingival granulation 
tissue samples were transferred to the bead tubes (NucleoSpin® Microbial DNA kit, 
MacheryNagel) and mixed with 250 l MG binding buffer and 25 l proteinase K. Tubes were 
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11 000g. 150 l of supernatant was transferred to a new tube and DNA was extracted with
phenol-chloroform method and precipitated with 3 M NaAc (Green and Sambrook, 2017).Pelleted 
DNA was dissolved into 50 l of TE-buffer.
P. gingivalis counts in gingival granulation tissue (including both tissue resident and epithelial 
adherent bacterial cells) and bacterial plaque samples were analyzed using a quantitative single 
copy gene-based real-time polymerase chain reaction (qPCR) as previously described (Hyvärinen 
et al., 2009) with some modifications. Reaction mixtures (total volume 20 µl) contained 2 µl of 
template DNA, 200 nM primers (Thermo Fisher Scientific) and 1x Universal KAPA SYBR FAST 
qPCR mastermix (KAPA Biosystems, Merck) supplemented with 1x ROX Low reference dye. 
Tenfold dilution series of the pJet1.2/blunt-Pg plasmid containing the whole Pg waaA-gene, 
encoding 3-deoxy-Dmanno-oct-2-ulosonic acid (Kdo) transferase, were used to generate standard 
curve. qPCR analyses were performed with the QuantStudio 5 Real-Time PCR System (Thermo 
Fisher Scientific) with following steps: Initial denaturation at 95°C for 3 min, followed by 40 
cycles of 3s at 95°C and 20s at 60°C. Dissociation curve was generated according to the default 
settings of the QuantStudio 5 real time PCR system. DNA extracted from saliva samples of P. 
gingivalis -positive subjects were used as a positive control and water as a negative control in each 
set of analysis. The data were analyzed with QuantStudio™ Design and Analysis Software and the 
results are presented as genomic copies/ng DNA. The detection limit for P. gingivalis was 23 
genome equivalents, calculated from the standard curves used.
Determination of Gingipain and Total Protease Activities 
To determine the P. gingivalis specific gingipain activity, fluorogenic substrates that contain D- 
amino acids [FITC-Ahx-(L)Arg-(D)Arg-KDbc (RR)] and L-amino acids [(FITC-Ahx-(L)Arg-
(L)Arg-KDbc) (rR)] were used (Kaman et al., 2012). The substrates were specifically developed 
for P. gingivalis and its gingipains, and their validation with positive controls has been previously 
published (Kaman et al., 2012; Galassi et al., 2012). A non-specific fluorogenic substrate, PEK-
054, was used to analyze the total protease activity in the samples (Janus et al., 2015). 
Either 16 μM of gingipain substrates or 8 μM of PEK-054 were added in 50 l of plaque 
suspension, tissue supernatant or PBS as a negative control, all supplemented with 2.5 M of L-
cysteine. The 96-well plates were read at 37°C for 1 h with 2-min intervals on a fluorescence 
microplate reader with Gen5 software (Ex:485 nm – Em: 530 nm, Biotek Instruments, Winooski, 
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previously described (Kaman et al., 2012, Janus et al., 2015). All enzyme tests were performed in 
triplicate and repeated 3 times.
Determination of hBD-2 and hBD-3 by Immunodetection
Protein concentrations of each sample were determined by the Bradford method (Bio-Rad 
Laboratories Inc., Hercules, CA, USA). A same amount of protein (10 µg/mL, 144 ng) for each 
sample was mixed with 5 µl of Laemmli sample buffer (4x), and the mixture was heated at 95°C 
for 5 min. Synthetic hBD-2 (0.034 mM, 4338-s, Peptide Institute, Inc., Osaka, Japan) and  hBD-3 
(0.034 mM, 4382-s Peptide Institute Inc.) were used as controls. The samples and purified proteins 
were loaded on 15% sodium dodecyl sulfate (SDS)-polyacrylamide gels at non-reducing 
conditions. After electrophoresis, the proteins were transferred to 0.2 m PVDF membranes 
(Trans-Blot® Turbo™ Transfer System, Bio-Rad Laboratories Inc.). Membranes were blocked 
with 5% non-fat dry milk at room temperature for 1 h and incubated overnight with primary 
antibodies against hBD-2 (1:1000 dilution, #AF2758, R&D Systems, Minneapolis, MN) and hBD-
3 (1:750 dilution, # PA1-4216Thermo Fisher Scientific, Inc., Waltham, MA) at 4°C. To detect 
hBD-2, the membranes were incubated with HRP conjugated polyclonal rabbit anti-goat IgG 
(H+L) secondary antibody (1:2000 dilution #81-1620, 4216Thermo Fisher Scientific, Inc., 
Waltham, MA). To detect hBD-3, the membranes were incubated with HRP conjugated polyclonal 
goat anti-rabbit IgG secondary antibody (1:2000 dilution, LS-C60884, LSBio, Seattle, WA). 
Loaded protein levels were controlled with Coomassie blue staining (Welinder and Ekblad, 2011) 
and protein transfer was controlled with Ponceau S red stain. The proteins were visualized using 
Clarity™ Western ECL Substrate (0.6 ml/cm2 area, #170-5060, Bio-Rad Laboratories, Hercules, 
CA) and ChemiDoc™ MP Imaging System (Bio-Rad Laboratories). The bands were analyzed 
with the ImageJ software (National Institute of Health, Bethesda, Maryland, USA). All 
experiments were performed in triplicate at 2 different time points. Results of the Western-Blot 
analysis were additionally verified by using different primary antibodies than described above (for 
hBD-2 LSBio LS-B13646, Seattle, WA used with 1:1000 and 1:500 dilutions and for hBD-3 
LSBio LS-C40649, Seattle, WA used with 1:500 dilution). Control experiments were performed 
by omitting the primary antibody from the immunodetections.
Cytokine Concentrations
Tissue concentrations of IL-1β, IL-4, IL-6, IL-10, IL-17A, IL-17F, IL-21, IL-22, IL-23, IL-25, IL-
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ɑ (TNF-) were detected by the Luminex technique (Bio-Rad, Santa Rosa, CA, USA) with the 
commercial kits (Bio-Plex, pro-human Th17 cytokine assays; Bio-Rad) according to the 
manufacturer’s instructions. Tissue extracts were vortexed, centrifuged at 9300 g for 10 s, and a 
same amount of protein was taken from each tissue extract to determine the cytokine 
concentrations. The limit of detection of the assay was 0.02 pg/ml for IL-1β, 0.52 pg/ml for IL-4, 
0.67 pg/ml for IL-6, 0.30 pg/ml for IL-10, 0.49 pg/ml for IL-17A, 0.80 pg/ml for IL-17F, 2.13 
pg/ml for IL-21, 0.30 pg/ml for IL-22, 1.55 pg/ml for IL-23, 0.07 pg/ml for IL-25, 0.49 pg/ml for 
IL-31, 0.58 pg/ml for IL-33, 0.43 pg/ml for IFN-, 0.41 pg/ml for sCD-40L, and 0.07 pg/ml for 
TNF-. 
Statistical Analyses
Data distributions were analyzed with Q-Q plots and the Shapiro-Wilk test. The IBM SPSS
V24.0 software (IBM, Armonk, North Castle, New York, USA) was used for statistical
analyses, including the non-parametric Kruskal-Wallis (for multiple comparisons) and Mann–
Whitney U tests and p < 0.05 was accepted as statistically significant. Associations between 
variables were evaluated with Spearman correlation coefficients.
Results
There were no significant differences in CAL, PPD, and ABL levels among the study groups. PI 
levels were significantly higher at Group 3 than Group 1 (p<0.001) and Group 2 (p=0.001). BOP 
percentage was significantly lower at Group 1 than Group 2 (p=0.007) and Group 3 (p=0.004).
Molecular forms and relative levels of hBD-2 and hBD-3 in gingival tissue samples are given in 
Figure 1. Both hBDs were detected as dimers appearing at ~12 kDa. Additional 3 bands appeared 
at 25, 37, and 150 kDa and were defined as light and heavy chains of IgG, as previously described 
(Herrera et al., 2016). There were no significant differences at hBD-2 and hBD-3 levels between 
the groups (Figure 1). 
In subgingival plaque samples, P. gingivalis counts and its gingipain activities, as determined with 
the fluorogenic protease substrate RR were significantly higher at sites with mild inflammation 
(group 2) and with moderate to severe inflammation (group 3) than at sites presenting solely with 
marginal inflammation (group 1) (Table 2). No difference was observed between the groups as 
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All cytokine concentrations were above the lowest limit of detection (LLOD) except for IL-4 
(29% under LLOD), IL-10 (22.9% under LLOD), IL-17F (16.6% under LLOD), and IL-23 (16.6% 
under LLOD). In descriptive analyses, cytokine concentrations below the minimum detection limit 
were substituted with a value of LLOD divided by 2 (Lubin et al., 2004). In gingival tissues with 
moderate to severe inflammation (group 3), IL-1β, IL-10, IL-17A, IL-17F, and IL-23 
concentrations were higher than in tissues with mild inflammation (group 2) (Table 4).
There were negative correlations between gingival tissue protease activity and hBD-2 (p=0.033) 
and hBD-3 (p=0.003) (Table 5). IL-1 β (p=0.007), IL-4 (p=0.012), IL-17F (p=0.035), IL-23 
(p=0.031), IL-25 (p=0.01), and IL-31 (p=0.039) showed positive and IL-33 (p=0.035) showed 
negative correlation with gingival tissue gingipain (RR) activity.
Discussion
The results revealed that hBD-2 and hBD-3 form dimers in gingival tissues and their levels 
negatively correlate with total protease activity. To the best of our knowledge, this study is the 
first to analyze hBD-2 and hBD-3 levels in gingival granulation tissue in relation to the hBD-
suppressing pathogenic activity (including P. gingivalis count, and gingipain and total protease 
activities) and hBD-inducing inflammatory response (Th17-related inflammatory cytokines). 
In the present study, the tissue samples were collected from periodontitis patients with various 
levels of clinical gingival inflammation, and granulation tissue of periodontal pocket was selected 
since it can be considered as the most active and appropriate site reflecting an ongoing disease. 
There was no ethical justification and clinical indication to excise sulcular tissue of healthy 
gingiva (no inflammation) from residual periodontal pockets with PPD 5-7 mm, thus no 
periodontally healthy control group was included in the protocol, which, however, may be 
regarded as a limitation of the study. Another limitation may be the fact that smokers were not 
included in the present study. The effect of smoking on tissue destruction in periodontal disease is 
well-described (Johnson and Guthmiller, 2007). Indeed, smoking may alter the innate immune 
response by suppressing hBD-2 in gingival epithelial cells as well (Mahanonda et al., 2009). A 
continuation study with smokers and quitters will enlighten the impact of smoking on the 
interactions between periodontal pathogens, inflammatory response, and gingival antimicrobial 
peptides. Finally, protease inhibitors were not used during sample storage and analysis in order not 
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as they are prone to enzymatic degradation, since sample storage and preparation at 4 °C may not 
inhibit proteolysis totally.
hBDs are small cationic peptides of 4-5kDa. We found gingival hBD-2 and hBD-3 in dimer forms 
at around 12 kDa levels. Recently, dimeric forms of hBD-2 and hBD-3 at ~12 kDa were shown in 
human tonsil cells (Herrera et al., 2016). The authors demonstrated that additional three bands at 
25, 37 and 150 kDa proved to be the light and heavy chains of IgG. These additional bands were 
also detected in gingival tissue (Figure 1). Our findings were validated by running the 
immunoblottings 1) at reduced conditions, 2) in the absence of primary antibodies, and 3) with 
different primary and secondary antibodies. In hBDs, dimerization is a precursor for higher 
oligomerization (Hoover et al., 2000). It was postulated that the presence of hBD-2 in the higher 
oligomeric forms facilitates its function by increasing cationicity and by enhancing the bacterial 
membrane permeability when compared with monomeric forms. In solutions, dominant 
oligomeric forms of hBD-2 have been found to be dimers (Hoover et al., 2000). Yet, it is unclear 
whether the dimerization observed in the present study is formed in the gingiva or after tissue 
extraction. Synthetic hBD-2 and hBD-3, which we used as positive controls, were also found in 
the same kDa region. As suggested by Suresh and Verma (2006), the observed peptide forms can 
be outcomes of the test conditions and/or high peptide concentrations. Thus, for confirming our 
findings, different extraction and analyzing techniques, (e.g., mass-spectrometry) will be needed. 
According to our results, tissue levels of hBDs do not relate to the severity of gingival 
inflammation. Previous studies demonstrated controversial findings in terms of the relation 
between periodontal inflammation and hBD levels; RNA and protein expression profiles of hBDs 
in periodontitis and in experimental gingivitis models were found to be elevated, steady or 
suppressed (Offenbacher et al., 2009; Pereira et al., 2012; Yilmaz et al., 2015; Dommisch et al., 
2015, 2019; Jourdain et al., 2019). Although our results are in line with the report of Li et al., 
(2016), in which no difference was observed in hBD-2 and hBD-3 gene expression levels between 
healthy and inflamed gingiva, longitudinal study designs are required to understand the shifts in 
inflammation-related regulation of hBD expression.
In the present study, elevated tissue levels of IL-1β, IL-10, IL-17A, IL-17F, and IL-23 were in line 
with the increase in inflammatory status of gingival samples. Previously, IL-1β and IL-17 have 
been shown to lead to an increased hBD-2 release from keratinocytes, while IL-10 decreased 
hBD-2 expression (Kanda et al., 2011). In our study, however, no relation was found between 
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cell (neutrophils, macrophages) infiltration to the sulcular granulation tissue may lead to a 
significant increase in cytokine levels. On the other hand, the disturbed epithelial structure and 
integrity in the granulation tissue may negatively affect the release of antimicrobial defensins from 
keratinocytes. Thus, characteristics of the sample tissue seem to have a major contribution to the 
levels of inflammatory cytokines and antimicrobial peptides.
Based on our results, a shift from marginal to mild inflammation is related to the elevated levels of 
P. gingivalis and related gingipain activity in plaque samples. On the other hand, no significant 
difference was found in P. gingivalis counts and gingipain activity between mild and severe 
inflammation groups. There are controversial results in regard to correlation between the levels of 
P. gingivalis and severity of gingival inflammation; both positive correlation (Demmer et al., 
2008) and no correlation (Suda et al., 2004) have been presented. Indeed, it was also proposed 
that, as an opportunist bacterium, P. gingivalis can subvert host defense mechanisms to prolong its 
survival and establishment in the periodontal pocket, but at the same time does not aggravate the 
inflammatory response in order to disable adaptive immunity (Hajishengallis, 2011). It is possible 
to claim that the correlation between the degree of gingival inflammation and P. gingivalis counts 
and activity does not necessarily be linear, but may have exponential and stationary phases. 
However, the cross-sectional design of the present study does not allow us to differentiate these 
active interactions between the host response and bacterium.
To asses gingipain activity, two different fluorogenic substrates (RR and rR), with different amino 
acid configurations, were used. These two fluorogenic substrates have been developed to detect 
the presence of P. gingivalis by measuring gingipain activity with a high sensitivity and specificity 
(RR has a sensitivity of 70% and specificity of 96%, rR has a sensitivity of 95% and specificity of 
73%) (Kaman et al., 2012). In our study, the tissue and plaque RR activities and plaque rR activity 
showed a positive correlation with the amount of P. gingivalis in the same sample. In addition, 
hBD-2 and hBD-3 levels had a negative correlation with total protease activity in gingival tissue, 
while no correlation was observed with gingipain activity. hBDs are known to be susceptible to 
degradation by bacterial proteases (Maisetta et al., 2011) and host proteases, such as by cathepsins 
(Taggart et al., 2003). Negative correlations between the total enzyme activity and hBD levels 
may indicate that the elevated bacteria- and host-induced protease activities in inflamed tissues 
may degrade or inactivate gingival tissue hBDs, leading to a shift from an insufficient innate 
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To conclude, subgingival plaque levels of P. gingivalis and gingipain activity and tissue levels of 
Th17-related inflammatory cytokines, but not hBD levels in gingival tissue, are related to the 
severity of clinical periodontal inflammation. Negative correlations between the hBDs and 
gingival tissue total protease activity may indicate the degradation of these antimicrobial peptides 
in progressed inflammation, which was previously demonstrated only in in vitro studies.
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Table 1: Probing pocket depth (PPD), modified gingival index (MGI), clinical attachment level 
(CAL), plaque index (PI), bleeding on probing (BOP), and alveolar bone loss levels of each study 








PPD (mean ± st. dev.) 5.15 ± 0.56 5.38 ± 0.81 5.16 ± 0.38
% of sites with PPD 5 mm 92.3 81.2 84.2
% of sites with PPD 6 mm 0 0 15.8
% of sites with PPD 7 mm 7.7 18.8 0
MGI (mean ± st. dev.) 1 ± 0 2 ± 0 3.26 ± 0.45
CAL (mean ± st. dev.) 6.23 ± 1.17 6.31 ± 1.25 6.37 ± 0.9
% of sites with CAL >7 mm 84.6 81.25 84.2
% of sites with CAL 5-7 mm 15.4 18.75 15.8
PI (mean ± st. dev.) 1.38 ± 0.51 1.75 ± 0.45 2.37 ± 0.5
% of sites with BOP 61.5 100 100
% of sites with mild ABL 76.9 43.8 42.1
% of sites with moderate ABL 15.4 50 42.1
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Table 2: Subgingival plaque counts of P. gingivalis and its gingipain activities in the study groups (Group 1: marginal inflammation, Group 2: mild 
inflammation, Group 3: moderate to severe inflammation). Enzyme activities are presented in relative fluorescence per minute (RF/min). p values in 








(Group 1 vs 2)
p value
(Group 1 vs 3)
p value
(Group 2 vs 3)
P. gingivalis 
(count)
1643 (1 - 108012) 29529 (1 - 72257) 17468 (0 - 118284) 0.012 0.001 0.78
RR (RF/min) 0.85 (0.25 - 6.5) 5.1 (0.55 - 17.75) 5.65 (0.65 - 33.85) 0.001 <0.001 0.52
rR (RF/min) 0.35 (0 - 2.2) 0.78 (0 - 5.65) 0.55 (0 - 8.7) 0.056 0.14 0.66
PEK-054 (RF/min) 0 (0 - 35.75) 0.06 (0 – 53.88) 0.13 (0 - 180) 1 0.85 0.78
RR: Gingipain specific substrate that contains D-aminoacids; rR: Gingipain specific substrate that contains L-aminoacids; PEK-054: Substrate to 
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Table 3: Gingival tissue counts of P. gingivalis and its gingipain activities in the study groups (Group 1: marginal inflammation, Group 2: mild 
inflammation, Group 3: moderate to severe inflammation). Enzyme activities are presented in relative fluorescence per minute (RF/min). p values in 








(Group 1 vs 2)
p value
(Group 1 vs 3)
p value
(Group 2 vs 3)
P. gingivalis 
(count/ng DNA)
6 (0 - 439) 11.5 (0 - 59) 4 (0 - 150) 0.81 0.71 0.35
RR (RF/min) 0.83 (0 – 9.67) 1 (0.5 – 37.2) 2.5 (0.17 – 65.5) 0.42 0.08 0.08
rR (RF/min) 46.3 (19.3 – 107) 55.08 (24.7 – 83.2) 35 (4.33 – 119) 0.95 0.38 0.32
PEK-054 (RF/min) 84.5 (35.2 – 128) 94.3 (38 – 130) 109 (16.2 – 172) 0.45 0.22 0.52
RR: Gingipain specific substrate that contains D-aminoacids; rR: Gingipain specific substrate that contains L-aminoacids; PEK-054: Substrate to 
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Table 4: Tissue concentrations of examined cytokines (pg/ml) in the study groups (Group 1: marginal inflammation, Group 2: mild inflammation, 











(Group 1 vs 2)
p value
(Group 1 vs 3)
p value
(Group 2 vs 3)
IL-1 33.46 (8.21 –218) 37.31 (8.64 – 177) 95.78 (6.71 – 287) 0.861 0.088 0.012
IL-4 1.01 (0.26 – 7.87) 1.01 (0.26 – 3.88) 2.33 (0.26 – 5.51) 0.619 0.229 0.031
IL-6 8.64 (3.14 – 80.11) 10.38 (1.88 – 116) 36.81 (0.86 – 190) 0.693 0.13 0.037
IL-10 0.7 (0.15 – 3.64) 0.78 (0.15 – 3.4) 1.88 (0.15 – 7.18) 0.738 0.049 0.024
IL-17A 9.04 (2.26 – 30.94) 7.57 (3.44 – 15.55) 19.33 (4.56 – 39.44) 0.948 0.037 0.002
IL-17F 3.16 (0.4 – 16.21) 3.94 (0.4 – 9.21) 8.38 (0.4 – 23.75) 0.965 0.094 0.006
IL-21 22.43 (10.71 – 75.43) 17.8 (0.66 – 72.2) 36.03 (8.3 – 90.41) 0.301 0.818 0.191
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IL-23 12.16 (0.77 – 103 ) 12.16 (0.77 – 41.37) 17.29 (0.77 – 77.37) 0.548 0.326 0.036
IL-25 0.89 (0.29 – 7.87) 1.05 (0.34 – 2.65) 1.78 (0.34 – 5.24) 0.775 0.077 0.021
IL-31 76.5 (36.62 – 576) 80.45 (36.62 – 216) 147. 12 (28.54 – 344) 0.809 0.179 0.029
IL-33 146 (20.38 – 582) 101 (41.7 – 585) 56.92 (23.02 – 463) 1 0.242 0.04
IFN- 3.48 (0.71 – 14.61) 2.9 (0.71 – 29.19) 6.06 (0.5 – 27.97) 0.553 0.161 0.079
sCD40L 39.55 (16.99 – 96.48) 38.48 (12.21 – 61.83) 38.27 (13.18 – 111) 0.861 0.908 0.96
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P. gingivalis plaque P. gingivalis tissue hBD-2 hBD-3
Spearman correlation coefficient, p-value
RR plaque 0.803, <0.001 0.198, 0.177 -0.078, 0.600 -0.010, 0.949
RR tissue 0.195, 0.177 0.383, 0.007 0.167, 0.256 0.021, 0.889
rR plaque 0.401, 0.005 0.334, 0.020 -0.009, 0.950 0.076, 0.609
rR tissue -0.142, 0.337 -0.237, 0.105 -0.041, 0.783 0.101, 0.496
PEK-054 plaque -0.136, 0.357 -0.336, 0.019 -0.146, 0.321 -0.092, 0.535
PEK-054 tissue -0.035, 0.815 -0.308, 0.033 -0.309, 0.033 -0.417, 0.003
RR: Gingipain specific substrate that contains D-aminoacids; rR: Gingipain specific substrate that contains L-aminoacids; PEK-054: Substrate to 










le Table 5: Correlations between hBD-2, hBD-3, P. gingivalis, gingipain activity, and total protease activity levels. Statistically significant p values 
(p<0.05) are indicated with bold.
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Figure legends
Figure 1: Molecular forms and relative levels of hBD-2 (A) and hBD-3 (B) in human gingival 
samples with different degrees of inflammation. In the western-blot figures, lines a and b are 
gingival tissue samples, and c is a synthetic protein. 
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